amlexanox has been researched along with Osteoarthritis, Knee in 1 studies
amlexanox: SRA-A antagonist;structure given in first source
amlexanox : A pyridochromene-derived monocarboxylic acid having an amino substituent at the 2-position, an oxo substituent at the 5-position and an isopropyl substituent at the 7-position.
Osteoarthritis, Knee: Noninflammatory degenerative disease of the knee joint consisting of three large categories: conditions that block normal synchronous movement, conditions that produce abnormal pathways of motion, and conditions that cause stress concentration resulting in changes to articular cartilage. (Crenshaw, Campbell's Operative Orthopaedics, 8th ed, p2019)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Sueishi, T | 1 |
Akasaki, Y | 1 |
Goto, N | 1 |
Kurakazu, I | 1 |
Toya, M | 1 |
Kuwahara, M | 1 |
Uchida, T | 1 |
Hayashida, M | 1 |
Tsushima, H | 1 |
Bekki, H | 1 |
Lotz, MK | 1 |
Nakashima, Y | 1 |
1 other study available for amlexanox and Osteoarthritis, Knee
Article | Year |
---|---|
GRK5 Inhibition Attenuates Cartilage Degradation via Decreased NF-κB Signaling.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminopyridines; Animals; Cartilage, Articular; Chondrocy | 2020 |